杭氧股份(002430.SZ):濟源杭氧擬斥2.35億元投建一套空分設備
格隆匯8月3日丨杭氧股份(002430.SZ)公佈,第六屆董事會第二十九次會議審議通過了《關於控股子公司濟源杭氧國泰氣體有限公司投資新建一套空分設備的議案》,同意公司控股氣體子公司濟源杭氧投資新建一套40,000m3/h空分設備為濟源鋼鐵公司供氣,以滿足濟源鋼鐵公司因產能置換升級新增用氣的需求。項目總投資額為2.35億元,將由濟源杭氧自籌解決。
公司表示,該次項目的實施有利於增強濟源杭氧的供氣規模和盈利能力,體現出用户對濟源杭氧所提供產品和服務的認可,對進一步擴大公司氣體產業規模、提升公司整體營利水平具有積極意義,符合公司在工業氣體領域的發展方向和長遠利益。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.